Cardiff Oncology Inc. Soared

Wed, Jan 18, 2023 at 06:58 PM

Cardiff Oncology Inc. (CRDF:NASDAQ) soared at $1.91, representing a gain of 23.2%. On Wed, Jan 18, 2023, CRDF:NASDAQ touched a New 2-Week High of $1.91. The stock appeared on our News Catalysts scanner on Tue, Jan 10, 2023 at 08:23 AM in the 'MISCELLANEOUS' category. From Wed, Jan 04, 2023, the stock recorded 55.56% Up Days and 50.00% Green Days

The stock spiked on Mon, Sep 12, 2022 at $3.31 with a volume of 1M+.

About Cardiff Oncology Inc. (CRDF:NASDAQ)

Cardiff Oncology Inc is a clinical-stage, biotechnology company, developing treatment options for cancer patients in indications with the greatest medical need, including KRAS-mutated metastatic...

Top 10 Gainers:

Ontrak Inc. (OTRK:NASDAQ), 94.78%
Magic Empire Global Limited (MEGL:NASDAQ), 44.29%
Energy Vault Holdings Inc Com Cl A (NRGV:NYSE), 34.83%
Sigilon Therapeutics Inc. (SGTX:NASDAQ), 32.95%
TC BioPharm (Holdings) plc (TCBP:NASDAQ), 27.79%
Sema4 Holdings Corp. (SMFR:NASDAQ), 26.78%
Faraday Future Intelligent Electric Inc. (FFIE:NASDAQ), 25.71%
Draganfly Inc. (DPRO:NASDAQ), 25.47%
Celyad SA (CYAD:NASDAQ), 24.74%
Cardiff Oncology Inc. (CRDF:NASDAQ), 23.23%